BuzzFeed (BZFD) Competitors

Oncology Institute (NASDAQ:TOI) and BuzzFeed (NASDAQ:BZFD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability.

Is TOI or BZFD more profitable?

Oncology Institute has a net margin of -20.28% compared to Oncology Institute's net margin of -32.51%. Oncology Institute's return on equity of -58.08% beat BuzzFeed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-20.28%	-109.10%	-32.26%
BuzzFeed	-32.51%	-58.08%	-16.19%

Do analysts recommend TOI or BZFD?

Oncology Institute currently has a consensus price target of $2.25, suggesting a potential upside of 355.28%. Given BuzzFeed's higher possible upside, analysts clearly believe Oncology Institute is more favorable than BuzzFeed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
BuzzFeed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media favor TOI or BZFD?

In the previous week, BuzzFeed had 4 more articles in the media than Oncology Institute. MarketBeat recorded 8 mentions for BuzzFeed and 4 mentions for Oncology Institute. BuzzFeed's average media sentiment score of 0.59 beat Oncology Institute's score of 0.12 indicating that Oncology Institute is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oncology Institute	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BuzzFeed	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in TOI or BZFD?

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 37.6% of BuzzFeed shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by company insiders. Comparatively, 20.3% of BuzzFeed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in TOI or BZFD?

Oncology Institute received 2 more outperform votes than BuzzFeed when rated by MarketBeat users. Likewise, 66.67% of users gave Oncology Institute an outperform vote while only 11.11% of users gave BuzzFeed an outperform vote.

Company	Underperform	Outperform
Oncology Institute	Outperform Votes 4 66.67%	Underperform Votes 2 33.33%
BuzzFeed	Outperform Votes 2 11.11%	Underperform Votes 16 88.89%

Which has more volatility & risk, TOI or BZFD?

Oncology Institute has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, BuzzFeed has a beta of 3.1, indicating that its share price is 210% more volatile than the S&P 500.

Which has stronger earnings and valuation, TOI or BZFD?

Oncology Institute has higher revenue and earnings than BuzzFeed. BuzzFeed is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$324.24M	0.11	-$83.07M	-$0.81	-0.61
BuzzFeed	$252.68M	0.41	-$88.58M	-$2.46	-1.14

Summary

Oncology Institute beats BuzzFeed on 10 of the 17 factors compared between the two stocks.